Aller au contenu principal
Accès ouvert déclaré 2022 preprint

Outcomes of Covid-19 Patients Admitted to the Intermediate Respiratory Care Unit: Non-invasive Respiratory Therapy in a Sequencial Protocol

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : es. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Recognizing patients that best benefited from non-invasive respiratory therapies (NRTs) in intermediate respiratory care units (IRCU) is crucial to ensure management and limiting resources during COVID pandemic. To assess factors associated with survival, intensive care unit (ICU) admission and intubation likelihood in COVID-19 patients admitted to IRCU.Methods Observational retrospective study in consecutive patients admitted to IRCU of a tertiary hospital from March-2020 to April-2021. Inclusion criteria: Hypoxemic respiratory failure (Sp02 <=94% and/or respiratory rate >=25rpm with Fi02 >50% supplementary oxygen) due to acute COVID-19 infection. Demographic, comorbidities, clinical and analytical data, medical and NRTs were collected at IRCU admission. Multivariate logistic regression models assessed factors associated with survival, ICU admission and intubation. Results From 679 patients, 79 patients (12%) had order to do not intubation. From de remaining 600 (88%), 81% survived, 41% needed ICU admission and 37% required intubation. During IRCU, 51% required non-invasive ventilation (NIV group) and 49% did not (non-NIV group). Longer age and lack of corticosteroid treatment were associated with higher mortality and intubation risk in the entire cohort and among NIV group; among non-NIV group, lack of corticosteroids (any regimen) was associated with higher mortality; Admission during the first wave, and higher serum lactate dehydrogenase (LDH) and C-reactive protein (CRP) were associated with higher intubation risk. Conclusions 57% improved at IRCU with no ICU admission. The use of corticosteroids improved outcomes. A bolus plus progressive tapering scheme could be more beneficial in severe forms. Initial NIV does not always mean worse outcomes.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Outcomes of Covid-19 Patients Admitted to the Intermediate Respiratory Care Unit: Non-invasive Respiratory Therapy in a Sequencial Protocol
Date Crossref
27/05/2022
Éditeur
Research Square Platform LLC
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Respiratory Support and MechanismsCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.